Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
WHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
Our experts help you stay at the forefront of the industry - and ahead of change.
New Medicines, Novel Insights
Discussions on Diversity
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
What can we help you find today?
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
By Chris Learn, Ph.D., PMP, VP, Head of the Cell and Gene Center of Excellence
Generative AI and how we can harness its power in clinical development
By Thomas Pietsch, Global Head of Scientific Data Technology and AI
Use of AI to develop health economic evidence for optimized patient access
By Jackie Vanderpuye-Orgle, Ph.D., VP, Advanced Analytics
Studying rare cancer patient populations using integrated genomic and real-world data
Why Rare Disease Therapeutics Need Early...
Beyond the Binary: Navigating Gender ...
By Rosamund Round, VP, Patient Engagement
Discussions on Diversity: Gender Identity
New Medicines, Novel Insights: Advancing rare disease drug development
By Rachel Smith, Executive Director, Rare Disease, Center of Excellence
Funding Biotech Innovation: How to ...
By Jim Anthony, President and Global Head, Biotech
Driving change in Cell & Gene Therapies:...
Optimizing the Route to Regulatory Approval for a Novel Vaccine
By Cecil Nick, VP Technical
Ensuring future success in a new market by delivering a robust safety database solution